Hypokalaemic quadriparesis
DOI:
https://doi.org/10.59779/jiomnepal.119Keywords:
Hypokalaemic quadriparesis, amphoterecin B, KalaazarAbstract
Amphoterecin B is nowadays being used frequently as a treatment for Kalazaar (visceral leishmaniasis). Hypokalaemia induced by amphoterecin B is a recognised adverse effect and a patient on amphoterecin B therapy may develop hypokalaemic quadriparesis. Such a case of quadriparesis is presented in this report.
Downloads
Published
2000-06-30
Issue
Section
Case Reports
License
Copyright (c) 2000 Journal of Institute of Medicine Nepal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Pradhan, B. R., Agrawal, J., & Oli, K. (2000). Hypokalaemic quadriparesis. Journal of Institute of Medicine Nepal, 22(1 & 2). https://doi.org/10.59779/jiomnepal.119